SWOG clinical trial number
SWOG-7430

5-Fluorouracil and Adriamycin in the Treatment of Incurable Hepatoma

Closed
Phase
II
Abbreviated Title
5-Fluorouracil and Adriamycin in the Treatment of Incurable Hepatoma
Activated
11/05/1974
Closed
06/11/1976

Research committees

Gastrointestinal Cancer

Publication Information Expand/Collapse

1977

Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.

LH Baker;JH Saiki;SE Jones;JS Hewlett;RW Brownlee;RL Stephens;VK Vaitkevicius Cancer Treat Rep 61:1595-97

1976

5-fluorouracil and adriamycin therapy for hepatoma.

LH Baker;VK Vaitkevicius AACR 17:215 #859

Other Clinical Trials

SWOG Clinical Trial Number
S1922

Randomized Phase II Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
12/16/2019
Accrual
1%
Open
Phase
II
SWOG Clinical Trial Number
S1815

A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers
Research Committee(s)
Gastrointestinal Cancer
Activated
12/03/2018
Accrual
100%
Open
SWOG Clinical Trial Number
S1613

A Randomized Phase II Study of Pertuzumab and Trastuzumab (TP) compared to Cetuximab and Irinotecan (CETIRI) in Advanced/Metastatic Colorectal Cancer (mCRC) with HER2 Amplification
Research Committee(s)
Gastrointestinal Cancer
Activated
10/09/2017
Accrual
25%
Open
Phase
II